FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Sumatriptan 10mg nasal spray (product) Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug)
Sumatriptan 20mg nasal spray (product) Product containing precisely sumatriptan 20 milligram/1 actuation conventional release nasal spray (clinical drug)
Sumatriptan 4mg injection solution prefilled cartridge Product containing only sumatriptan in parenteral dose form (medicinal product form)
Sumatriptan 5mg nasal spray (product) Product containing precisely sumatriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug)
Sumatriptan 6mg injection solution prefilled cartridge Product containing only sumatriptan in parenteral dose form (medicinal product form)
Sumatriptan 6mg/0.5mL injection (product) Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan 6mg/0.5mL injection refill (product) Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe (product) Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe (product) Sumatriptan succinate 12 mg/mL solution for injection
Sumatriptan succinate 6mg/0.5mL injection (product) Sumatriptan succinate 12 mg/mL solution for injection
Superfamily scolioidea Superfamily Vespoidea (organism)
Superfamily vespoidea Family Vespidae (organism)
Superficial partial thickness burn of hand, unspecified (disorder) Burn of hand
Superficial pressure sore plaie de pression de stade 1
Superficial pressure ulcer (disorder) plaie de pression de stade 1
Superficial temporal axial pattern flap plus skull Superficial temporal artery osteocutaneous flap (substance)
Superior oblique muscle innervation disorder paralysie du nerf trochléaire
Superorder Marsupalia (organism) Infraclass Metatheria (organism)
Support removal Splint removal
Support removal (procedure) Splint removal
Support removal Splint removal
Supraglottis TNM finding (finding) American Joint Committee on Cancer allowable value
Surgical construction of fistula (procedure) Construction of shunt
Surgical margins Surgical margin (morphologic abnormality)
Surgical repair - action action : réparation
Surgical repair of small bowel (procedure) Operative procedure on small intestine
Surgical repair procedure by focus réparation chirurgicale
Surgical wound necrosis (disorder) Surgical wound necrosis (finding)
Suspect cystic fibrosis fetus Suspected cystic fibrosis in fetus (situation)
Suspect fetal anencephaly Suspected foetal anencephaly
Suspect fetal damage from maternal alcohol Suspected fetal damage from maternal alcohol (situation)
atteinte fœtale soupçonnée en présence d'une toxoplasmose maternelle Suspected foetal damage from maternal toxoplasmosis
Suspect mongol fetus Suspect trisomy 21 fetus
Suspected angle-closure glaucoma Angle closure glaucoma suspect (disorder)
Suspected damage to fetus from disease in the mother Suspected foetal damage from disease in the mother
Suspected damage to fetus from disease in the mother, NEC Suspected foetal damage from disease in the mother
Suspected damage to fetus from environmental toxin Suspected fetal damage from environmental toxin (situation)
Suspected damage to fetus from intrauterine contraceptive device Suspected fetal damage from intrauterine contraceptive device (situation)
Suspected damage to fetus from maternal alcohol addiction Suspected foetal damage from maternal alcohol addiction
Suspected damage to fetus from maternal drug use Suspected foetal damage from maternal drug use
Suspected damage to fetus from maternal listeriosis (disorder) Suspected fetal damage from maternal listeriosis (situation)
Suspected damage to fetus from maternal rubella Fetus with suspected rubella damage via mother (situation)
Suspected damage to fetus from maternal toxoplasmosis Suspected foetal damage from maternal toxoplasmosis
Suspected damage to fetus from radiation Suspected fetal damage from radiation
Suspected damage to fetus from viral disease in mother Suspected fetal damage from viral disease in mother (situation)
Suspected glaucoma due to type 2 diabetes mellitus (situation) Glaucoma suspect due to diabetes mellitus type 2 (disorder)
Suspected glaucoma of bilateral eyes caused by steroids (situation) Glaucoma suspect of bilateral eyes caused by corticosteroid (disorder)
Suspected glaucoma of left eye caused by steroids (situation) Glaucoma suspect of left eye caused by corticosteroid
Suspected glaucoma of right eye caused by steroids (situation) Glaucoma suspect of right eye caused by corticosteroid (disorder)
Suture of spermatic cord Repair of spermatic cord
Sweet potato - dietary Sweet potato (substance)
Swine vesicular disease virus (organism) Human coxsackievirus B5
Symphalangy Syndactyly (disorder)
Synchephalus twins Syncephalus
Syncytial endometritis Exaggerated placental site (morphologic abnormality)
Syngamus laryngeus (organism) Mammomonogamus laryngeus
Synovial sarcoma - category (morphologic abnormality) Synovial sarcoma
Syntactical aphasia Syntactical aphasia (finding)
Synthetic antiandrogen (substance) Antiandrogen
Synthetic patch repair action : réparation
Syphilitic gumma of other sites (disorder) Syphilitic gumma
Syringing - action Irrigation - action
Systemic chondromalacia (disorder) polychondrite chronique atrophiante
Other acquired deformity of finger, NEC Deformity of phalanx of finger or thumb
Systemic inflammatory response syndrome associated with organ dysfunction Acute organ dysfunction due to systemic inflammatory response syndrome (disorder)
Systemic vascular resistance Systemic vascular resistance (observable entity)
Systemic vascular resistance Systemic vascular resistance (observable entity)
Systemic vascular resistance (observable entity) Systemic vascular resistance (observable entity)
Systemic vascular resistance Systemic vascular resistance (observable entity)
T-shaped fracture T-shaped fracture
T-zone lymphoma Peripheral T-cell lymphoma
T0 category (finding) American Joint Committee on Cancer cT0 (qualifier value)
T1 (I): Cervical carcinoma confined to uterus (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Endometrial tumor confined to corpus uteri (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Trophoblastic disease confined to uterus (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Tumor confined to vagina (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Tumor limited to fallopian tube(s) (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 (IA): Trophoblastic disease confined to uterus with no risk factors (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 (IB): Trophoblastic disease confined to uterus with one risk factor (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 (IC): Trophoblastic disease confined to uterus with two risk factors (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1 category (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor < 2 cm in greatest dimension (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor < 2 cm in greatest dimension without extraparenchymal extension (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor confined to ethmoid with or without bone erosion (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor confined to nasopharynx (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Breast tumor <= 2 cm in greatest dimension (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Clinically inapparent prostate tumor not palpable or visible by imaging (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Kidney tumor < 7.0 cm in greatest dimension limited to the kidney (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Lung tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Solitary liver tumor < 2 cm; no vascular invasion (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Testicular tumor limited to the testis and epididymis without vascular/lymphatic invasion (tumor may invade tunica albuginea but not tunica vaginalis) (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor invades lamina propria or submucosa (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor invades submucosa (colon/rectum) (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to ampulla of Vater or sphincter of Oddi (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to ipsilateral parietal and/or visceral pleura (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to one subsite of hypo-pharynx and < 2 cm in greatest dimension (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to pancreas and < 2 cm in greatest dimension (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to subglottis (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to the antral mucosa with no erosion or destruction of bone (finding) American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility (finding) American Joint Committee on Cancer cT1 (qualifier value)

Start Previous Page 106 of 132 Next End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start